Let-7a and EWS-FLI-1 in Ewing's Sarcoma
Author Information
Author(s): De Vito Claudio, Riggi Nicolo, Suvà Mario-Luca, Janiszewska Michalina, Horlbeck Janine, Baumer Karine, Provero Paolo, Stamenkovic Ivan
Primary Institution: Faculty of Biology and Medicine, Institute of Pathology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
Hypothesis
EWS-FLI-1 directly represses let-7a, contributing to Ewing's sarcoma development.
Conclusion
Let-7a is a promising therapeutic target in Ewing's sarcoma, as its restoration inhibits tumor growth.
Supporting Evidence
- EWS-FLI-1 directly binds to the let-7a promoter, repressing its transcriptional activity.
- Restoration of let-7a expression significantly decreases tumor growth in vivo.
- Let-7a overexpression leads to reduced expression of oncogenic target genes like HMGA2.
Takeaway
This study shows that a tiny molecule called let-7a can help stop a type of cancer called Ewing's sarcoma from growing.
Methodology
The study used miRNA arrays, chromatin immunoprecipitation, and in vivo tumorigenicity assays to analyze the role of let-7a in Ewing's sarcoma.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully replicate human disease.
Participant Demographics
The study involved pediatric patients with Ewing's sarcoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website